The Crick Science Entrepreneur Network (CSEN) is excited to host their very first series of talks and panel discussions.

About this event

Crick Science Entrepreneur Network (CSEN):

Recently established early this year, CSEN works alongside The Francis Crick Institute Translation Team to promote and develop entrepreneurship within the scientific community. CSEN aims to bring together researchers at all career stages to learn about the translation and commercialisation potential of their research, and about how to get involved in innovation and startups in the life sciences area.

CSEN events will share the experiences and journeys of founders of academic spinout companies, or scientists who have transitioned to a career in innovation, venture capital or technology transfer.

About this event (time GMT):

16:00-17:00 Panel discussion

17:00-18:00 Networking session with panellist and attendees

Join us on December 1st for a hybrid panel discussion (see Covid-19 measurements below) with three inspiring panellists: Jason Mellad (StartCodon), Laura A. Lane (Advent Life Science) and Marc Moesser (Creator Fund). They will discuss their interest in emerging fields in biotech as investors, board members, or founders of accelerator programs.

If you ever wondered Which topics do biotech investors find really exciting at the moment? What are the current “hot” technologies in biotech and health tech? Are there any underexploited niches?

This event is for you! You will also have the opportunity to ask our speakers questions throughout the panel discussion.

This event will be hybrid, but we encourage everyone to show up in person to The Francis Crick Institute to take advantage of the networking opportunity following the panel discussion. Due to COVID , all attendees are required to specify their intention to attend in person and must comply with the COVID regulations set out below.

About the speakers:

Jason Mellad, CEO and Co-founder of Start Codon

Jason is a scientist entrepreneur passionate about translating innovative technologies into better patient outcomes. As CEO and Co-Founder of Start Codon, a Cambridge based accelerator, he aims to identify and recruit the most disruptive healthcare startups worldwide, seed fund them and leverage the exceptional resources of the Cambridge cluster to de-risk and drive their success. Previously he was CEO of Cambridge Epigenetix and Business Development Manager for Horizon Discovery’s diagnostics division. He also served as an associate at Cambridge Enterprise, the technology transfer office of the University of Cambridge. Jason was awarded a Marshall Scholarship to obtain his PhD in Medicine from the University of Cambridge. Linkedin

Laura A. Lane, Principal at Advent Life Science

Laura is a senior member of the investment team at Advent life science. She joined in 2019 bringing business intelligence, business development and executive leadership experience. Previously, Laura held CEO and COO positions in a number of life science and biotech startups. This included leading the Series A fundraising and being a founding member of management in VirionHealth. Prior to that, Laura worked at Warwick Ventures focusing on business development and technology commercialisation, and Black Swan Analysis, a boutique consultancy advising pharma and biotech companies on asset valuation and product forecasting. Laura gained her MSci in Chemistry and PhD in Structural Biology from the University of Cambridge. Linkedin

Marc Moesser, Investment Partner at Creator Fund

Marc is an investment partner at Creator Fund and an Ideas 2 Impact fellow at the Saïd Business School. He is also the Co-Founder of the Oxford Venture Capital Network, focused on connecting stakeholders of the startup scene in Oxford and beyond. Previously, Marc interned as a management consultant at EY-Parthenon in Munich where he focused on the Life-science sector. He holds a MSc. in Biological Chemistry from ETH Zurich and a BSc. in Biochemistry from Heidelberg University. Currently studying at Oxford for his PhD, he is developing novel machine learning methods for the early stage drug discovery pipeline. Linkedin

Follow CSEN on LinkedIn, Twitter or subscribe to our newsletter on our website to find out about our exciting series of talks and workshops on entrepreneurship!

Covid-19 Measurements and Restrictions

We highly encourage you to attend in person to this exciting event. To ensure your entry, please have access to your Eventbrite registration and evidence of your double vaccination status or an NHS registered negative COVID lateral flow test taken within 24 hours.